- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Ascendis Pharma
Market Cap: US$13.6b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$221.88
7D
-4.0%
1Y
32.1%
Madrigal Pharmaceuticals
Market Cap: US$10.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$441.16
7D
0.07%
1Y
27.4%
Insmed
Market Cap: US$29.3b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$136.00
7D
-5.9%
1Y
71.3%
Alnylam Pharmaceuticals
Market Cap: US$41.4b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$312.17
7D
-2.1%
1Y
7.4%
BeOne Medicines
Market Cap: US$30.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$275.28
7D
-5.0%
1Y
8.7%
BridgeBio Pharma
Market Cap: US$13.3b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$68.54
7D
-3.5%
1Y
84.1%
Ionis Pharmaceuticals
Market Cap: US$11.7b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$70.99
7D
-1.9%
1Y
112.2%
AbbVie
Market Cap: US$362.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$205.07
7D
-7.4%
1Y
-2.0%
Jazz Pharmaceuticals
Market Cap: US$11.1b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$180.62
7D
-0.8%
1Y
27.2%
Eli Lilly
Market Cap: US$810.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$906.70
7D
-8.3%
1Y
4.8%
BioMarin Pharmaceutical
Market Cap: US$10.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$54.13
7D
-5.7%
1Y
-24.8%
Natera
Market Cap: US$27.7b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$195.28
7D
-1.2%
1Y
26.9%
Viatris
Market Cap: US$15.2b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.20
7D
-2.3%
1Y
41.9%
Royalty Pharma
Market Cap: US$26.2b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$45.36
7D
-1.6%
1Y
34.4%
Exact Sciences
Market Cap: US$20.0b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$104.91
7D
1.0%
1Y
122.8%
Elanco Animal Health
Market Cap: US$11.9b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.98
7D
2.5%
1Y
124.3%
Waters
Market Cap: US$29.3b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$298.99
7D
3.1%
1Y
-19.9%